Medicare Part D rebates ‘substantially’ reduced drug spending, but not enough to offset price hikes

18 September 2019 - As controversy continues over prescription drug pricing, a new study finds that Medicare Part D spent ...

Read more →

Price controls for Medicare don't put America first

17 September 2019 - Instead of embracing drug price controls, the U.S. should pressure other nations to abandon them. ...

Read more →

When are RCTs required for breakthrough drugs, HDEs? JAMA study investigates

11 September 2019 - A new study in JAMA Network Open finds that drugs and medical devices approved by the ...

Read more →

How to correct this big Medicare mistake

10 September 2019 - It's a big mistake to assume that Medicare is the only health insurance you need in ...

Read more →

Bernie Sanders went to Canada, and a dream of ‘Medicare for all’ flourished

9 September 2019 - The Vermont senator has staked his presidential campaign, and much of his political legacy, on transforming health ...

Read more →

Medicare drug price negotiation — why now . . . and how

4 September 2019 - A targeted bargaining strategy using tried and tested arbitration techniques could help Medicare balance drug innovation and ...

Read more →

Proposals to redesign Medicare Part D — easing the burden of rising drug prices

4 September 2019 - Amid concerns about high drug prices, policy makers are considering options for modifying the Medicare Part D ...

Read more →

Promoting paediatric drug research and labelling — outcomes of legislation

28 August 2019 - Congress has modified regulations of the FDA to promote research assessing the efficacy and safety of drugs ...

Read more →

Pharmacists call for Medicare rebates for medical consultations at the chemist

15 August 2019 - Pharmacists are pushing the Morrison government for changes to the Medicare system to allow Australians to ...

Read more →

DHB backs PHARMAC in making ‘hard calls’

7 August 2019 - Hauora Tairawhiti has a role of supporting drugs-funding agency PHARMAC in its ‘‘hard calls” but not ...

Read more →

PHARMAC considers funding breast cancer drug Kadcyla advocates have been fighting for

7 August 2019 - The Government's drug-buying agency PHARMAC is considering funding three new drugs - including one which advocates ...

Read more →

Health insurers walk delicate line against Democrats’ health proposals

31 July 2019 - As Democratic presidential candidates take aim at the health-insurance industry, companies are striking a delicate balance, ...

Read more →

Medicare for all instead of private health insurance? Question vexes 2020 Democrats

28 July 2019 - Some presidential candidates drew fire after vowing to abolish private insurance, and the issue will likely surface ...

Read more →

CAR T-cell therapy: a microcosm for the challenges ahead in Medicare

29 July 2019 - The search for more effective and less toxic therapies for cancer has occupied scientists for decades. ...

Read more →

Medicare paid for medicines that three other wealthy nations decided had little value

24 July 2019 - As the U.S. grapples with rising prices for medicines, a new analysis finds Medicare spent more ...

Read more →